← All Sponsors
SPONSOR

Shanghai Virogin Biotech Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Malignant Solid Tumor
NCT07262164 Phase 1
Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors

Advanced Malignant Solid Tumor
China View Trial →